Net profit of Medicamen Biotech declined 36.89% to Rs 2.19 crore in the quarter ended December 2025 as against Rs 3.47 crore during the previous quarter ended December 2024. Sales rose 3.92% to Rs 46.91 crore in the quarter ended December 2025 as against Rs 45.14 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales46.9145.14 4 OPM %9.3414.86 - PBDT3.946.09 -35 PBT2.113.88 -46 NP2.193.47 -37 Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 13 February 2026.Powered by Capital Market - Live News

Net profit of Medicamen Biotech rose 82.88% to Rs 2.67 crore in the quarter ended September 2025 as against Rs 1.46 crore during the previous quarter ended September 2024. Sales rose 5.43% to Rs 47.17 crore in the quarter ended September 2025 as against Rs 44.74 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales47.1744.74 5 OPM %10.9411.87 - PBDT4.544.56 0 PBT2.681.96 37 NP2.671.46 83 Powered by Capital Market - Live News

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live News

Medicamen Biotech announced that the 32th Annual General Meeting(AGM) of the company will be held on 26 September 2025.Powered by Capital Market - Live News